Brand Name(s)
RINVOQ®
Drug Class
Targeted Synthetic Small Molecules
How taken
oral
Used for
moderate-to-severe ulcerative colitis
Recommendations for Pregnancy
Do not use upadacitinib if you are pregnant or plan to become pregnant. Based on animal studies, upadacitinib may harm your unborn baby. You should use effective birth control (contraception) to avoid becoming pregnant during treatment with upadacitinib and for 4 weeks after your last dose.
Recommendations for Lactation
Upadacitinib may pass into your breast milk. Do not breastfeed during treatment with RINVOQ and for 6 days after your last dose.
Medication indication
moderate-to-severe ulcerative colitis
Indicated for pediatric use
No. Not currently approved for pediatric use.
Most common side effects
Common side effects may include headache, fatigue, acne, nausea, urinary tract infection, and elevated cholesterol
Other
Taking upadacitinib may include risk of serious infections, blood clots, certain types of cancer, and may increase risk of death or major cardiovascular events .
To see the full prescribing information for this medication, click here.
Scroll right by clicking & dragging with your cursor or swiping with your finger.